This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.
Denton has held various leadership roles, including senior vice president and controller/chief accounting officer and has previously worked with the management consulting firm of Deloitte Touche Tohmatsu.
These are among Deloitte’s predictions for life sciences and the future for drugs companies and their operations, from The Future Awakens: Life Sciences and Health Care Predictions 2022 (Deloitte, November
A study published in December by Deloitte showed that R&D costs have doubled in eight years, while peak sales forecasts have halved.
The research by Deloitte’s Centre for Health Solutions found returns had declined 1.8 percentage points from 3.7% in 2017. ... Deloitte says the industry needs to tackle the problem with new ways of working and emphasis on finding the right talent.
According to a Deloitte report, AI ‘can help analyse large data sets from sources such as clinical trials, health records, genetic profiles and preclinical studies; within this data, it can recognise ... Deloitte also suggests AI can help improve study
According to a Deloitte survey, 75% of British companies are now pessimistic about Brexit after weak investment and waning revenues in the most recent financial quarter.
More from news
Approximately 2 fully matching, plus 18 partially matching documents found.
A recent analysis by Deloitte showed that most new drugs continue with the revenue trajectory set at launch – around 70% of products that miss expectations at launch continue doing so in
According to Deloitte Insight’s 2021 Global Marketing Trends report, purpose is one of the key aspects necessary for businesses to flourish – they need to understand why they exist and who ... According to a 2019/20 Deloitte survey, 68% of biopharma
Rare diseases: setting the gold standard for successful product launches. A recent Deloitte Insights white paper found that three product characteristics are strongly associated with strong launch performance: priority review and
The Prescrypt project, spearheaded by Deloitte in the Netherlands, is pursuing a completely different focus by working to put patients’ drug prescriptions on the blockchain for secure communication, usage tracking and
Deloitte’s Future of Work initiative highlights the increasingly important role that contractors, freelancers and external experts play in building the flexible and agile teams that companies need.
More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.
Prior to that, she held several senior communications roles, including chief communications officer at Deloitte, as well as senior roles at Novartis, Pfizer and leadership roles at biotech and healthcare communications
Stockdale arrives at the company from e-Therapeutics, where he had been financial controller since 2012, and has also previously served at Deloitte as a senior manager.
Previously healthcare and life sciences partner at Deloitte Consulting, Vogt has experience advising companies in the medtech, healthcare and pharmaceutical industries in implementing and improving strategies. ... Prior to his experience at Deloitte
Prior to this, Souza held the role of chief financial officer at Aetna, overseeing its guaranteed products business, and has also held senior leadership positions at Deloitte and PriceWaterhouseCooper.
He brings 20 years of financial and managerial experience to the role, having worked at Deloitte, Eaga, PriceWaterhouseCoopers and Barclays, where he headed up its North East corporate banking division.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Advisors. Genesis Research was advised on the transaction by Clearview Healthcare Partners, Deloitte, Palo Alto, Piper Sandler and Ropes &Gray.
Ropes &Gray acted as legal advisor to GHO; CIL as commercial advisor; Alvarez and Marsal as financial advisor; Deloitte LLP as tax advisor and CRS as insurance advisor.
The COVID-19 pandemic has brought into sharp focus the need to harness and leverage digital tools and technology for remote patient monitoring (RPM). With the onset of lockdown, and a sense of unease when visiting conventional clinical settings,
Ladana Edwards, Partner at Deloitte Central Europe and Thomas de Bruyne, Consultant with Deloitte Belgium, share their thoughts on the future of education and the role of digital technologies such as
Deloitte, 2019.Last accessed February 2020, available at: ). Accenture, 2019. Last accessed February 2020, available at: . Public Health England. Last accessed February 2020, available at: . 44 (0) 20 7009 3100. Address:.
More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.
We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...